ae all
Pharmacology logbook Pago 6
Section 1. Clinical Pharmacy
A. Dosage forms and drug delivery devices
By the end of this module the student must have acquired knowiedge and skills pertaining to:
Medicine label.
Generic versus branded medicines,
Enumerating the diversity of dosage froms and drug delivery devices.
Use of oral solid dosage forms.
Use of oral liquid dosage forms
Use of inhalation drug delivery.
Use of injections, infusions and implants.
Use of topical dosage forms.
Setting up IV infusion.
Setting up blood transfusion,
‘Administration of oxygen
Carefully remove the label from an expired medicine pack / container of a prescription
only medicine in India and stick it here. Note the various elements in the medicine label
3x sma Dosage Foren & Totals
Sitagliptin50mg& | |. Gener Name &
7 H | Active. ingredients:
Dapagliflozin 5 mg Tablets i sel Lene
Sitapride-Day =,
Dosage Strevg tt.
Serre 50/9
I—> Manufacturers Name.
Compare and contrast Generic versus Branded medicines
Branded medicine
Generic medicine
"Medications comtaiuing same ae *Medieatint sotd undes a trackamaal|
ingredient as bron. medicine bub) nome ley A plasmatetical com
Jeol under clanteat/non-orendek — Hat cievihopeli fecenr ro"y
Je They ARS much cleapey. o They arc expensive. ~
le Broven to le (ofoequivalint to lavemdle Con Sfoleaect as Stenctadd wsten |
Seas first infrecducedt. Geuerte Ares rmall
a rato tte ¢ hemctaad +
flocks Att fevenr di“ Fadtraak *Oulgu appeanwrnce Gy yer
laos. A 6 |, |ichanty. Also approved after
bockies Fete Ie en er extance CUR Skat dotl «pharmacology logbook Page7
Enumerate the diversity of dosage forms and drug delivery devices here. =
pee ere *Semi- Soli Desegt, forms *
Do forms 2- TeOtutwunt, Creamy Geds
one Dosage i Pactes, Uniucouts
« Trramsclermas drug te Uvery
System .
Clowable Tats
Enteric Coated TH
Te : ae
ty. Extendect Release SooMtS” |e SupposMonies » Smplomts-
ae Doyy Delivery Devices o—
vile S ing uel tatolete, J Spingee & Nbeckies
vilir Mould act +etolers
ix. Pettots.
X+ Powders.
ie Snfus Por pumps
iis Auto-tafec ters ( theutn ens)
fue Sntratlers (MOI, Kotatater)
ib: Loaenges or Troclus. Ve NeloutPoers .
* Liquict Dosage hoevag 4 — [vt Smplrrtable chevfers
. Snjectins. ee Vile Tromedsmal patebet-
eit drops /Nasad < prays
eae val al any cletivery
*+ Uipesomal of Arlive
sytem “Ef "7
Draw schematic diagram of a transdermal therapeutic system (transdermal patch)
7 > Prlietive Fen
| Brug Conteh
"A Recorton. Cl
3 5 Ralf Controtbitg Memls
oe 2h qs havin pervect
tLe Ga + te a ™ Adbeste layer 6
> — we OS Bier
“a
2 Tharapeuki Ske layer (Cfeculation)
fy Toren Trerepeutte % layPharmacology logbook
Page &
Note down the steps in use of the following dosage forms
Metered dose inhaler
stake +60 Prhaleato uix the
meclPeaton pr
eA «
° Remove +Ge P
*Kensnge et wdle Hho ta
p)Ptie he Prlales lay Wotds
ol TE sprny Tle cab
ae.
est ie + & Gobate
lank. aA ory your
© PLleethn mouthePeoeF
yo uy ece tn |
Fegey sana Rectal postage
@ Snake te wredPoation
ethene, ‘
Stomuttpmcously bg presing Ge
eHold Your Breath by IOeca.
° Boldt Sloot iu a
° Keploce +H.” Cop & Rfrse
Youa Moute-
Rotahaler
Conhpaarment,
*Stomd or Sft
wT Ups.
© Cham +2 2D:
e Open tie wotahalia =
oTneeat tGe medical x
Capeule Pn tho Ane
* Cloge 462 votalialey lo:
Preeshy the tse halves &
Fere eo
Stond ov SF desig to
Open UD adr nay se
pOsclaie cue Core Bs
> Place tex mouk pred € 1)
[yous rout Ba Het OT soo
le On lrake. the gnedicadtion
deeply &aqut
“Hols ah oped +6, for tO see
B etemhale slowly:
wal cloth or actissuz paper &
Rinse Your mouth +
worth
Subcutaneous injection
eSeloct thi2area (upper asm,
, Aoclomen )to be tjectad|
fess Oe oa
potent préferen
© Use the sterile dry prepavatig
meomt for sula-cutam ests injections
eUse a shost tO ueddle,
© Tibcten toes k Pry hold #2 c pig!
Cieza pencfl B insert. the
needle at meas slfn-
fold at om ong 20-30°
2 Dutt toack 4a plunger gentty »
iFuo blood pass in thw
sy infect Vea cry Stee:
Jp OTA awd neoctle quoter
& press sterile susale Tato tee
opentig Br Fx uit adtasive
ee
* Cheon » Afspore sfisasle
Sofelt & wetk pomds.
Intramuscular Injection
glovese
muscles
ot
Je StEdrows ws
For shaap vo
* Th case amy blo:
Side eflecks.
ePerform hand Wjafene & vwoear
Oneover the area +o loe fafecliel
e Clean the sfte ushisg Atco!
chavactertees & uncover: Cf cust tater ef
* Allon the site tock
© Punt of the cay
eTeu the atten to velar the
e Insert the needle soi fry atan|
te Go*, . 7
le Sryect sloust CoS - 2 nid)
eDrgcard the s priage Fr abettofn
We a day sFeatle Fece =
Soa egies Sect
: erat ate patient fr Y
a re motion
eae
Pein ttre needle.
te aoe
od oozes, Patnen °Uf Gleed oozes outs Fed Ate ance
eee ate Aon fe Eres pentans
Eye drop/ ointment Ear drop ane et coe
eyed j poe <
Le) te J-ro0am te ear Arops loy keepr
ottex acute) 2 Was your lemd$ «beau tn -tCue orn SO eb conn ll
‘oe coun ot Fn eee nae a P
° +02 patieut—to (Sale & fie -+ec2. DUS Fe
ecebstte rashes eStats fie Teh teas, beed oteromal or Ue
exiucg ten Aro per cloce-to ttusye [it Gently Pull the loloe ~to erpese
[= Bly eee prbsesPoeet amount &f-| Ce eat
pelo epteleQrtnt, dase cess |, Sete Ge ammount Sf ers
at “ease . cided +
Armed) + Lek tee atts We [ys LoaSt foe min wefore faci
ack pot aah +0 the Of062A BAR.
«TEs eve should becletellyt. Vee cotlen Loost 10 closotEg
Pharmacology logbook
Page
Note down the steps In uso of tho following dosago forms
Intravenous Injection,
le Perla homd by gens fh wocaa loves
le Uncave x ~ICvo 1A completely
lersk-IC.e parte -tovelax & 4 e
HOe a8 ‘loclor +C.e yetn-te be
Apply -rournsq uch Br look-fora
port
used
suitable vei,
* Vint For tex vetnnlo swett.
P Clean tre aile usivgy alee rot
SOEs B) ALLOrS +CLe wart chy.
Jo Putt
one we PS oe
CTC eR inte rea cones
es
fe Keep fis heat shrots
Py
Eye Ofubuent ane oppltest ti
jSarmre woo as ere reps.
ean Canad
ee era
LLPharmacology logbook
Note down the steps In use of the following dosage forms
Page 10
Nasal drop
© Blow the nose.
© Si don Bet lb hoadk backwar
6 a
Of chops precenloedl
+ Smmectfatety afinnaact fl
Hho head \Jerm fe
re
Bed ta
between +e ky
°SPt afles a fev seoonds|
ee ede Ht dniptotGe
Mariynoes
° Kineetie coo;
‘io ost tG
bof lect roolEa
02
@ Inserttée dropper leno Fate | Lefe Biche POSPtee Kenee briget)
He Uoshil & a +e amoutl| bent -towwaads ates
Pep
re tte enomalk?t:
erode tasjoua bende
° fe cetfent on +CaP ir
° Lularioati Eve. now
ZB Pnseat the eremea -Hy fato
He veotur alsoud 2-Sinokes
Pn adults » less -frr ett ld ren:
PAdutafeter 4he , solution, beg
fal SIO serersivg Hee
wecturm oie
° orn the ene tna?
a. Keiatn ta & teen roten
tie urge Ps chong» Use fae
latersom —to expet the
BULUAR eomtentss
© WALh your tromdt: |
© Mortfter the effects Eivelre f
fir con statis
Rectal suppository
2 Wash tha bends
2 Luboefeatt the ends witG
A “9ahig- soluble (worteamt
o Put ongtoves
° Snsext -+tG2 s
into the rectum
tn of toe #
the upp
wp alea
ETT yn
ot:
upto eel
sot
he
“noaga-the lomds.
Vaginal suppository
© Wash the Komds
© Prepare tes = pottery
° Get tnto a cortintatatl
position Uke Fn Uttotomy
posttor
posPtim.
© Snseat tee supp my
qenry into 402
© Le atoum for a fer minutes.
© Wash your hemds.Pharmacology logbook
Pago 11
Note down the steps and precautions in setting up
Intravenous Infusion
DA mG oe te uot &
2a SF nook
[Droctebiieg For | for Gaclcf af
eaaes pump to conbrot
FIs rate By mrroud dey th
ad l +
Blood transfusion
one ® |i)
1) Pesferm Land iH
Desiam Sm poset Phan aR. water oe. fnelu “ef
D Gather Supplies Dpicoot lor papa
% Crroosh sutigioavern& amen mee eetunad
Claas +O SPU oshtG, andi. | Correct ea By motels
soph ripe & terete Pobenty ae tood +a pe-
IDAu Tv Gus Pe Poort
Tato averus us
+E orm oy
‘DTine blood) rensfucion
once P ie 120 wA [bor
ouce bl & seen rewore | DT, patient i¢ clocel
th useclle Gr cores] Dt pai tor 2
BD Privates Th toh +o et a tremsfusion red ck
Temove afr lbutolo! & “fo inst ak [Sndn,
ee bag on pole orally 35 as paren P Shodote
eae Free Fe Pees pomatusion role cam bbe
zs CHR tes ie T/v Vitel of cole
Dennett ine ah viel een tit
QIV nes arzrvemovect
roms:
Assesewe xf patiots
ornate
2d [rain or
fae storot
ot ST heals 160 en
LE Nz.
Fill-up the following table on oxygen delivery devices used in your hospital
maT
‘Other notable features
ose of, davon axinum fowate—[F,
musatcannunipronge [| 1- © L/rnty _[25-4Spfe? OS USE EE or Oreo”
Face mask (simple) G-S L/min |4O-6oP+ ISvould nok be used corte |
Ventur mask 4-8 L/min | 2u-407 eee: Ae Se ceagt
= 10 = 1S L/min [10-1007 ite etl
= GO L)min [I-07 [Serre aR oot cid
uppv ewes. 8 | 1¢— 720L/rmin.| | DOF: ReeeCH nena eno as
mamma, [20-600/-~.] 1007. feiuts uae eireaey
NRBM = Non/rebreather mask / HENC = High flow nasal cannula / NIPPV = Non-invasive positive pressure vesiavon BAP
= Bievel positve airway pressure / CPAP = Continuous positive airway pressure
Teacher's signature
upon section completionPharmacology logbook
Page 12
Section 1. Clinical Pharmacy
B, Preparation and use of Oral Rehydration solution (ORS)
‘ho end of this modulo the student must have acquired knowlodge and skills porta
cy ‘c _ Rationalo for oral rehydration therapy. ane
+ Composition of ORS with its osmoiality
J Reduced osmolarity ORS.
«Method of preparation using ready-made ORS powder.
© Correct administration of ORS.
«Assessment of dehydration and rehydration.
Write down the composition of World Health Organization (WHO) recommended ORS.
Sriinal formula Tovised formula (Reduced osmolarity ORS)
Component Amount per Liter] Corapouent Amount/t @)
——W | Nact — 26
Nac _ a.co | Tetspctfium CPhralz— 2+
detuycdrate
Tei soduws lee
Pai ydeatl — ae Ket ———
Ka
Glucose (rnlyyjavous) — ao [2A a GS mmot et
rer Gemma I terns
Kt 20 wol/L .
Stow > BOmmstle egmeteity Tote Osmolost?-+ty=
3
~ Vs eNat —— Fommot/L
© CPhakk— —1omol/L
2 Glucose —> AEmmet/L *
Totat
ep Glucose > ttimmstic 31min 24S A Oomn/L-
Mention the purpose of each component of ORS.
Component a
Brom. [rete tae Mane este camer
Glucose pag ee th vooder alosorpifon via sockFu mm glucose,
Porasstum
Ciilovicle.
© Gta Prices quick sousce sf 2: ye
SRopinces poiaesium loss fy Uarstaa. aie
eChlowmale Lelps Mamntaty elecbolyle lbalomer+
[SokFarn
Ri-castonat|
Act, as a buffer +o correct Metabote access
* Corrects acid-base Pmbatemce+
Ta¥sockfum
clrate
7 CFs is more Stab & effective them Sicaavo-
hale En ORSpharmacology logbook
Page 13
Clinical assessment of dehydration and rehydration in childron ~ list the sallont points.
Changos notod in dehydration when it is
Clinical characteristic
Mild to Moderato Sovore
Geucral Appcaromce|Trattabley Alerts Thiasty. letCang ic untonfront
T
Capi lary FPLUisg Slightly Letayed Delayed
Pelee, Rapral » Lexo volume weale & + Cyreody
Respiration Nowmat to Prcveased nerenseat
Prreled Slr _| Bove F ay no temting laumcce oe :
Eyes KMormal to sunken oe
Urine Output | Noemea to Reet meena
renerally to be repeated every 4 hours.
Note : Assessment s 9
Write down pointwise the method of preparation of ORS (using readymade ORS powder),
appropriate use in children and the counselling that needs to be done for the caregiver.
Goumst ug #—
[Frepasatiom of ORS 2- ous
Gor! & coet one Utre sfwala| eile maa betieg oreget Beto
contuue Sreask a.
» Open ORE sachet B act +e esfalild wot breast feds
{iole content fo oe Irae la gid vation oa ee
ee cree Set ew [Eup rece oeeelonss
Ps ready Ue & r develop, Stop ORS ® eons
“ebputd be Usredl within 24 | plain water or breashkmrlic
hours: \ HU PUtFess Afsappeass -
_Appropriadz use tn childrev, of 402 ctf ld vourtss
re] CO for 10 ER MINS & thon
Dat tslusect-fo prevenk er overci
ftuid Coss as | slowly staat ORS-
cenyaration dete
Bake cinch arngumiet ok6 Fu *Solutin prepared to los
Re Bae
evtsy episode of Bie reer |e ca aie ec
EEE a Spouse t—
Puatd den <2yrz —3 SD-l00u4 of one
«Children aebyes 7 loo- 200m 5
+ Children > to yrs 7 200-260 Sf ORI.
Teacher's signature
‘upon section completionPharmacology
Page 14
Section 1. Clinical Pharmacy
C. Pharmaceutical calculations
By the end of this module the student must have acquired knowledge and skills pertaining to
® Weights and measures used in compounding and dispensing activity.
® Concentration and dilution of liquids and topical medicarments.
® Stock solutions.
‘* Dose calculations involving body weight.
# Dose calculations involving body surface area.
© Dose calculations involving parts and proportions.
© Dose calculations involving reconstitution of dry powders.
Dose calculations involving parts and proportions.
«Dose calculations involving reconstruction of dry powders.
«Dose calculations involving flow rate IV preparations.
Weights and measures used in compounding and dispensing activity
Based on discussions held in class fil-up the following tables
Metric ‘Symbol Multiples of base unit Mass example Volume example
system prefix mass/vo lume
li) Plo kK V/ 10 Taree le?loli tre
—4 / —! 2, °
2 10 crarany Plitbre
D veel a 10 be 4 Dec? i
> Con? a Lo S/o? Coutipram Cont? Pre
aur om Lotfi 2 REM greme EUR
5) Mir Mh oft of MPe neem, [ttereU re
Units from other systems Metric system ‘Common household Metric system
Used in compounding and equivalents measures equivalents
dispensing acti
iy
Avotrdupers Syslin D I Teaspoon fit Sm
Ipound —> O°ASKA | |) 5 Le csert spoonful low]
Jy Trey Sys lin
lounce —> O ene
DGattem Systin
lgatirn — = 3H:
Di Talotes peor Fatt tg]
1 dreP 0-0Smlpharmacology
centration of liquids and topical medicaments
Page 15
Concentration rene in cas itp the ain en
Method of
‘expressing Meaning Examples
concentration
Weight per unit volume
Amount of mass present 1
untd volume Tre cleustty.
Adult Hb Concentraken
——_ 13-14 rg lau
Weight per given
volume
Amount Of mass present IH
a given volume
Pruenytoin aval ble
as 260rmyq/Sr\ Conc:
Percentage
Concentration wiv
Amount of solute per
'Boml ext Sotn-
SY. Aantrose (Byrn
toord|
Percentage
‘concentration viv
Volume of Solute per [00m
of soluton
Fro mP of alocolute
aleottol in loOml ot Pts
aqueous “solukmns
Percentage
‘concentration ww
Amount of solute fa gqrams
Per looml of solution:
Benzorc acfol 127. Gy
)
Ratio of parts
Relation bir entrees
work thie Companahive a ay
100,000 Epineplainelin} D
Dosing of tropical medicaments.
Based on discussions held in class fl-up the following tables
Region to be ‘Approximate amount of topical | amount in terms of finger tip unit (FTU)
covered medication required* (in 4
Face and neck fae re
and beet) es 13-s7
‘One arm .t Qs
‘One hand o-G aes
‘One leg 2-4 ae
One foot oF Ae
Whole body 20 40°
* Single Ight application in adult person
Meaning of FTU
gre Riawneter em denctivg
[fore finges +o ventral as
amount GF Statmmenbh, ream or SeumPsolik Lesage
Horen 2 bruced Prom a tse
notte a uoorte of
trem is teterease cg
pect St -—fuces-Hp-
whose dose may be
expressed in FTU
Examples of medicines
a
ctepfeal atersidc.
clrocorticonsy Betawetilncone & 0
\pharmacology logbook
Page 16
Explain the meaning of the following in relation to stock solutions with suitable examples
rc
Stock solution
St ts a lagge volume Sf Comman reagent
Oto slomdbacise’ conamtration t
Qa” AM of HCL preparech from 16M Hel
Stocte+
; The procese of acing mere solvent ty
Dilution a solute Ps cated ' L?lution-
MM, Snitat molaiky
MV) =MoV9 Mg Final revo tae ey
Vj Pritial Volume
vg— Ainat Volume -
To caleulale prporifons of ony too
Solukoms to ac wi¥xet to prTepere
Lenat solution of destrec concenhaten.
Dilution equations
Alligation
Dose calculations based on body weight and body surface area.
Note down examples discussed in class.
QA child's wey Fe l6poundc. Adutt hose Ps loogy/d
yea ropabele close re the child, a
— By claak’s Formutas
q| doce in eluld = LOCO Adult dose.
Igo
= [00x _ 10:67 Boa.
so
Qi) The etald hac becky suaface ance Ff 0: G7tm>
ye ie a etl » Pind dose =Porterctild.
— Dow Pr cldld = AckuIt bose * Body eushace A220
Adutt looky eux face Ai2a-
=_©7F » 0-67
Tx
= 264g ]4e1*pharmacology logbook
Pago 17
Antu ent (drops =
Dose calculations related to Infusion
remember the following Infusion equations given
alongside:
Flo ate (nt 1)»
ote down examples discussed in class
‘yA patent &s to vecfeve IL af Reuger Laciose
Zoietfor over the wesc (2 bre: Dereantve 104
tufusion rales ff traa drop tor ?.
hon rat placer Ps 60 dept
_ + Snfusion reali = Volume x Drop-factnr
Hurection ~-[ infucen
= 10
COX6O _ £333
12” 60
Q2) Snfusin 5 (voomL we" clerctroee trvcnnet
“eobur 1S to be given oves Cuouss-
Coreutale < tlre -ft akin H OAso THE
dvie vets ff ayop factor Ps Sqft:
— FI valz = Volumt = loOO ~ wad [bh ,
we Dweto S a
Drip walt = Vol x Davp-factyr
Time
= 1900x ISL 2 dropyfn? an.
GO X —— id
Teacher's signature
‘upon section completion|
logbook
Pharmacology 10a} Pago 18
Section 2. Clinical Pharmacology
A. Prescribing and prescription review
By the end ofthis module the student must have acquired knowlodgo and skis pertaining to
= Meaning of prescription, the ideal prescription format, common accoptable abbreviations.
Do's and don'ts in prescription writing.
Legal issues in relation to prescribing e.g. prescription of narcotics and other controlled drugs, banned
drugs. prescribed for sportsperson.
Prescribing for commonly encountered clinical situations.
ion and prescription audit.
Prescription review, prescription reconci
Define the term prescription
A presemipttian fs A vortten orden Gy a loctor Fo a
pharmacist to Aispense the gtatet medPePues ov
ee therapeutic ts Pu +e ape ci fret stremgt&s
closage foam & Qucmttigy te a pasdPeular PoctFeat .
del prescription in the space below and identity its parts
Write down a simple mor
Dr. ABC
ase MBBS
g Regis trocimnd
384 4 x Address
panne Centact: no -
Ages Sen?
Address *
ley ho
eB &
Tals Let Aatterromy chu S00 “4
Gat
ef Dispense Such Staite
“7 (each eon talahng sore)
dteit +o be taken 4 hour befere meal
ws once daily for © days.
o ABC
3 Dati Reatsiation
Trumioes.logbook
Pharmacology lo} Pao
Note down some common abbreviations used In proscription with tholr moaning
[Ropevation | Meaning Foweviation | Wenning
Tord [es B-@ | Diccontuu
tid Htrtce datly x lice s
[ aid [four tine s a deny Yo Nease olel
Ac before meats! om morris
Pe After meats pro | aft. noch.
IV Sn bavenous ly
TM _| On rramuse thi
Subbt Subeutaneoust
ss ome Lalf
I wdater
State what are controlled drugs (in Indian context) and provide some examples
A contiotedt drug Psa chug or Otter subselance tose
marnufacire » possessions sate Er use are Halt |
controllid & rvesteretet by tHe ovean ments bedeuse
PL may be abused or cause ack dictfen .
a4 Mov plPuc Cocke Puc) Amplrets aoe
State what are banned drugs (in Indian context) and provide some examples of recently banned
drugs with reasons for banning
Banned dregs BAe TAOSt (Ste AGE PROLILIER for
mauufactue! & sale by Ate government because of
rds effects trel last ol varticatte -fotet.
pst reasms &—
4 St causes upper GL aed I Caahine
C fea pve
DROP aor artiyeuntal Sy heater:
© Practo lol 4 St causes Octo mucocetancous
syndromes
@ Auatain > Bone Margoro depression.
@ Nine sul Pele — Gauses hepatfe feP lune -Pharmacology logbook
By the end
Section 2. Clinical Pharmacology
B, Adverse drug reactions and drug interactions
of this module the student must have acquired knowledge and skills pertaining to
Meaning of adverse drug reactions (ADRs) and its implication in pharmacotherapy,
Different types of ADRs with examples. including serious ADRs,
Pregnancy risk stratification of drugs.
Meaning of the term pharmacovigilance and various pharmacovigilance strategies
ities of the pharmacovigilance program of India (PvPI).
Objectives, structure and acti
Brief overview of other nation
program, Adverse effects following Immunization (AEF!) progral
(MPI).
Spontaneous reporting of ADRs.
Page 26
nal adverse event monitoring programs e.g. Herbal pharmacovigilance
im, Hemovigilance program of India
© Basics of causality assessment.
Meaning of drug-drug interactions and its implications for pharmacotherapy.
© Different types of DDIs with examples.
«Examples of DDI involving modern drugs and herbal medicines.
© Examples of drug-alcohol, drug-smoking, and drug-food interactions.
Situations that increase risk of ADRs 1 DDIs like polypharmacy, high alert medication (HAM)
and sound alike-look alike (SALA) medication.
Define the terms Adverse Drug Reaction and Drug-drug interaction
ADR Avg response Tattels Te Vrortoudy Umintencted
B eleeceuas at closes nermatty usedtn
lumens for por pry axis s dfagnon's Hoare py
of dfscasey ov -for modifeatton of plry ciolesy ic
=fuaction:
DDI Pacthe meahawitmn of acho ofa
drugs, vresut Huq PA an array oft
ae 3
dma toy Tee concomitant ad uPure trot on oft
suSktemtes Such aS food » lbeverges ov otter
sie eF fects
List examples of
Type AADRs
ror lad, |wetatid +o Pt praamace tox
Gang
VLR of wouter, bierney
[DSrcke effects} Atropine produces any
Uw vel
B)Seconelansy |. Corticoctersidt couece
Predictable reacttons to at
call actions.
wos)»
beantion.
Ronen anette
ef wWsion,
lead to © ppustunistic Pnfections lk
2 Tooctc |, Bleecti Austs Ovesducas wt ante oa,
effects [Uke rSla-fartn, Neptre torte, ratte, av
aty.
IF
Petre ORE
rression nStG
fe ovat Cometic
geben
of
Le
awit
jiatePharmacology logbook Page 27
‘Type BADRs
Pearre
(ora RE eti0n3
Nom tose velalécl wv npr eclic table Yeacttane
Ho Aodlruqg etPelt ane uot velatid +0 Co]
prasmecG| leg?cat actin.
Rasy Briteth due +e exposure -bo peutes Uru.
Derg pee) tence tt einen prodlicedl by quinictive
Phrihs wits AlSaAlD ¢.
Contact de ooh
dermatitis due 40 localornosilu tye ¢-
D)Sckte rey — Aplastic au *
DY eproy Pare queue caused Oy # Xlorervnplir tue ct:
‘ : is.
— Hemolytic aucuia seen where
Gedous ADRS Potential) Ufe thrreatitays Cause ¢ Rrrerne. F
Jatamase or requtre Clintensive mecticat
treatGhont -
D DrqosePu—F Veu brPeutas bac bry cork
LD DOS teeta es & Cmca
D borbi Salis — Respiratory cLepressionts
Pharmaceutical DDIs|
“The PuteractHons Occur laefore A russ one
actualy wtinPsterect to tie palbert &
repre su incom pan bi i a
D Hepaam + Te hr ey tine SnaeHrabian st
jd) Antares + Sucrat-fale —> Vices proGetve e Feel
Deaton Feha + Gatiamine 7 Musehe re laxemt
ettect ic inevreaset
D wastertn + Gingko bilo ba—s Onereasedt
Herb-drug
Interactions blee tic .
2) Calor propandicde + Alum Gobrvwm qd
—"_typegiyernein
Food-drug
D) Mao Phe? bors + Cleese > Maliguank
hw P ry tension.
Dd qeaew ot Antieoagulants — Snereasech
of suctatfate is leet
D plens teint Deschere —y forms fr selubtecalt &
Prarmaconinete D GF Fam tt6Fasid et, hx Aecrenieet tr |
|2)Kifewupfeks roc Pe fetuses Tf co teacspbens,
Dliproftoxacin + Treoply wine — Palpitations ; Convules
Pharmacodyramle D Eaata pei [+ SP frone lactme Re anes /
_
bleeot’
‘4Pharmacology logbook Pago 28
Note down foatures of tho following casuality assessment scalo
World Health Organization-Uppsala Monitoring Center casuallty categories with featuros
genes tedeie
The SHO“ OME Sys Ps Cambincd a
atte tiie $= Phasmac ole:
cal aspects
wy anol phe aoc fl of oloc umentateh,
Rute account
of the case vo
dausatity {erm Asseasnent Corl
_ eEveut oY Calcorators tect Ub nov ma UE
Cevtatu plausible Hace re tim stup be olruy intake.
O warn eGamot be ercplarucel by Cereea sa oO Ottor
aoe s
bu.
£3 pharmacelag? catty = —
© Event ov LAbovatory fest abibormalli ty
Goransal plauw
@fessibvle Ne peconatcle Hurelrelaione® p to dai
~ intatre « . q
eCould also be ercpltned Ce cUiseaces oy
Ones kvept :
eo Snformsitfon on trug votttictrawal mea
ee toe lacteivsy + q Y
@ Prbvatte / Event ov Cabboratony desk Aner matitey
Wet WH Yeasona ble W-Hmae welatiom sp
A +0 clvug intaie+ >
C Ont éade “to toe. atl Mbuled +o decease &
ofuay a clay +
ebvenk or een FESE COB ALY esis
a tue +o clu, Putalke,
e Disease ar otter d << provide plow
lceneckaay mgs P e
@ unekety
Wwwns ae
@ cond? Honal [+ Event or Cats test aburnanty
~ > |e Mowe data for proper asses rent neececl
© vnc tase*Fatte.|” Report suaaes Rey on AavreR ge oT
RAL AL | Data comnot tae supple wenlict er verilie|
List examples of
High alert Tntravenous Leparing Oneutiny DY potassiwm,
medication in the narcotesr .
ITU setting
Sound-alike look- Deukei ne a Bopaws “
alike medication that | AAr-erra_line , Albeo pire
you have come 5
a Morphine, Peter clinePharmacology logbook Page 29,
Exercises on case sc
enario based filling up suspected ADR reporting form
Scenario 1
Mr. Prakash Jadav, a SSyear old man weighiug alour
cous came to Medical Colleges Kolkata on 25/68/2020
astttt fevers CLI US 5 pafn ful slam rashes » swelling of
Ups: On exanduation, tender, purple voide react
prastes on Ls loacks cect, upper abdomen were
noticed. +t7s. Tevealedh 4eat Ke had an attack éF|
muppets Pnfaactfon TA +e recent past. tte
stdated talcPus Tab. ASPIRIN Sma at nigts treodays|
back & cdevdtopet tte eyrmproshs on 24+ 06-202
He was advi +o Stop tte of Pramechiately Ga
was presczilbed tab: Predurcoloua. ACter Bolays he
recoverect+ FFL, ADS fos:
Scenario 2
Mr. Neranlar Mo: pe man oF AS 4/0 > e4, esky
loame +o tee OPP af Medical Co @ on Ol+ ce?2020
Lotte, qeneralicect body ache » Pictifug Bskin yacues.
He gave the Lis ot trtone of Aor FUR
for ttreahwenk oF Resp: Tract: snfectionss lon prevfous doy]
lm +2 symptoms appearect immediately afrer taufusieg
Hrug- On exaninatfon tere rere Ps puss
SUA Tastes ON lott. asms ,foreosams Ba -Ffromt sttte|
eben. The aX woas stopped ee eaeegenee || Sha
wag treated He ante La stand wes. SAFtes
Adays le recovered. Fru up the ADR -form-
Scenario 3
Mrs- Kunt? Dew’, aSSyrold lady woetg et Se “a> octey
Hee OPP oETISMSER, rsofi nausea Bish eprsode:
hamatemesie & modenalt epigastric pata omnia: 2
vstPeh Kas occured afunce Last 3 Lovys CA/2/21) + The
poas Lo futake of Tabs Ibuprofen A0omsg Drstee dasl}
sfrce Lact Qmenth<. Endoscopic exaniuation reveals
erosion Pu Lower eetestesataan
mucesel Yegion: She was advised Yo Manediately step
ite Ars « He woas tremtent vohte Tt: Robey rancte 20
Htostee AM Ply closfings After Golays <4e4
relieved Tera eee ADL fore, Oe Spemplersget
‘Scenario 4
7 Raesk Gan, 4% y/O; male phy roapeing aloouk Te
re areas Sto ed silence bn noe koosd doh te
JSwollan Ups tHe gave tee Lister, of talek Ts Rawstp:
basn 08 after ‘oreanfach the +e at it SE}
vyperthacton om the Lact day rotich was frst
staateds “The symptoms arcsec last nh + He das
fastructed to 'Rumudfately stop tte tolrug. Te
Levecetrratre (0 Ob al us voas arSlen »
He became symptom freed from 21-G.2020-
FEA up ae AO “
esopragest Buppes gashig
nckPharmacology logbook Pago 30
SUSPECED ADVERSE DRUG REAC
er i i i ete Sree
Reg. No, APD No. OPD No. CR No,
"AMG Report No.
Worldwide Uniaue No.
5, Event/ Reaction start dato (ddimmiyyyy) 2 4 J,
S Event /Reaclion stop date (ddimmiyyyy) 2 B/ 6
6_(A) Onset Lag Time Adays.
cacribe Event Reaction with treatmbnt detalls, ran)
mreserdtedt Wott fever, clubs]
astrewe : 2 ecgrancy
bseltven ee Ups Pa neat sin rashes. NA
ge, tender, Purp UE pstdespreadk
A on tea! back, [ia seronmesToTn
act. Dr seems ruati] em)
Taboratory data with dates
N/A
Cleity Upper 4 [5 Death (daimmyyyy) 2 Congenitat-anatomy
Sr of Asplhain’ By ak wl Tebra Hon OF [5 tie meatening 5 bisattty
Talos PREBNISOLONE Ld-to TA 5 Hosplaiation/ Prolonged C) Other Medically imported
15, Outcomes
I Recovered Recovering _ChNotrecovered
vecovery of ta petrent +
Fatal Recovered wih sequelae ) Unknown
SE
S-No]s.name __|Manutacturer| Baten | Exp. Dose Frequency] Ther seus
(Grand’Generic)| (iknown) | No.! | Date (it | used (00,80 [Date Date] Indication | aSsessment
tio known) te) | started _| stopped
ASPIRE pratt on—leefeleo|zs/efeal MI —|Prebatde
n
i
We
5. no] 8 Aalion Taken (Pease HR) To: Rewdion eappeaied air reitoaucton(pessech)
2 | ee Bun] inoSacea | mbuces | appicanie | Unknow} | Yer No | tectunknown | pose (reinoduced
7
o
it
We
"f, Concomtant medical product Including seltmedication and herbal remedies with therapy dated (Exclude those used to treat reaction)
fs.wo] Name (Breng/Generie) | Dose | Route | Frequency (OD, Therapy dated Tndlcaton
tea | sed | Bo.) S aa
started | _ Stopped
1 Preduatclems | — [oral = 2s 76726 Cont
[Additional information Pie ae
Pint fem
‘el. No. (with STD cos
‘Occupation Slonatur Doo
17, Date ofthis report damm) 147 S/202S~
Sig. and Name of Rec
‘Confidentiality The patient's Identity Is held in strict confidence and protected to the fullest extent. Submission of a report
does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the
reaction. Submission of anADR repor does not have any legal implication on the reporter.
age for more informationPharmacology logbook Page 31
FORM
SUSPECED ADVERSE DRUG REACTION REPORTID
Fos VOULMTAIT ecertng df Karen Ory Paacten by Meaercare censors
Worldwide Unique No,
5, Event | Reaction start date (ddimmiyyyy) LL] 2020 |
%. Event / Reaction stop date (ddimmiyyyy) S/e o N/A
6. (A) Onset Lag Time Sdosys -
| pexcribe Even Reaction with treatment details. any — 13, Relevant medical! medieation Raton (og. sTeraies
Tone prescuied woites a oaralied [Pmgtrncy™ nome mowers onto
Poet Cig sticling » stele rashes
of 1, Cee, purplish skit rashes N/A.
vaseds ol kA +AL 2075» fore- [= SS
3 anyone
head, frompetctesh » Catfenl | |5\oemniaammnm) 2 Congenittanstomy
recovered 4 days after Ascent 15 ute areatening 5 oistaey
huaten of frspectedt frug & 5 Hosphatization / Prolonged Compuli adver tizement-
Stato some of the ways that you may be misled through drug promotional literature
ie ey false pletosto Pllus trations, .-
2° A use of voorads UPke “only pee ov “maar
emecty 2 ral adverts.
3 Lack Ze onleguole lato. om adverse Aug
rvovrolek od verttsors
rreachons rat
a6 Distortion » om, ede eurphasic,
ouctesion or Pu ouny ottes
se clisesip Hong such ay defer &
eno et he oe ppeate”
G+ NS Pater pretation of p ulo Ustrol lata
4+ Focused , matention gratiteg Dr banet
dyiven over Hee wonts
B+ Lack of person Knowledkee3
pharmacology logboo! Page 36
tame some impartial sources of drug information
— Sele? fre Tourxnale.
2
J) Po
2 Secondaay—> Snolec
eatcles -
Ar Promotional — fold
Snternotonel Plas maemo
e
ar lerHooy —> Compendfa, test vooke ,revPeva
internet, curate.
mae, Mod Ure,
Abstracts.
ers» leave belt
(eof.
What do you think are the pros and cons of interacting with representatives of
pharmaceutical sales personnel (medical representatives) ?
Pros
e Qntrocluces a nev
produc Pr the market
e SQnevreases prospeck
e Sncareagea sales.
oe campetitom.
0 Enhances geod wr tl of
cement
© Educalts +62
wo ket
© EP Pralid niPdollemen
e Sotesmam lu p supped.
° Raiqes stomdaadof
Cons
° be inadag vote,
Prvetilkd or mois endliy
PLeads td miouopol
TAX past q
bremlA af proctuck-
© Crealis agtPf rai ol
dewaud sf +e product
© Snerernges preter of
ACR jorocluct.
° be tras ful for
sou
st
eEnhomes art
pation’
nrecdiceth 7
a
Teacher's signature
upon section completionpharmacology logbook
Page 37
Section 2. Clinical Pharmacology
D. Rational use of medicines
d of this module the student must have ai
py the en equired knowledge and skills pertainin,
«Rational use of medicines (RUM) and its three pillars - essential medicines ln eon
standard treatment guidelines (STG). ann aeen eee
Framing of an EML for a given health ffacility / healthcare scenario,
Sources of drug information.
Extracting information from non-commercial and commercial formularies.
Basic steps in promulgation of Standard Treatment Guidelines (STG),
Steps in exercising the P-drug concept.
List the drug promotional strategies which you can think of
Rational use of medicines —» Accordit to WHO, ratoual use oF mediahes
requires that S patents Cl pecieve meckieations appropral
Ho teste OLPuPoot needs P closes teat meat +euir oon
mrajority of +e pope
quttity Javar Goat
lati one Sheutd be ot ascured
au tites 5 Py adequate quam+tHHe
Hes &% Fu approprale
roqmuaysPovenara] Pa a Comttuusdiy recieve compilation
of phammacent” & Inelucli Tm porte + Pra Formation
+Ga4 reflects +Ge cussert “ecrrcat Sadigenment
of ta wiedfeal staff.
‘Standard treatment guidelines or protocols Stemdaad -Heatmauk, quiditines
te Aofined At Systema te PLevetoped stalimenr
desi +o assist practitfouer ES patents Pr note
decisions abet apy WolE hKeatt care for specie
CLintcal cireum wa S\A2Ht Grown eFatectolers TYE"
mettiasone tablr/Snj-
are n Omterrourbearote +atoler<
gr! Wm aNHs 29 e
Gace Veo sem Sin yee! 7
sme tutablet s)Albeucta s0te- ty DAapiafitamuts @ Poaacctanel
pond oni + D levocetsfaPre tal ~tetolats +
Bina tewnrmyeho rallar aS flte [aS ee gerrena sete toate.
eoroFtomacts tales dant re Omeprazcte capsule +
Dani Tod . Matoeial WHrogtycesty tab Let +
“ys “ES | I Dlatvetelot tro let *
‘university class field trip into a tropical forest_| Emergency department crash cart
[Loperanside tatolet. DSnJ- Adrenaliue 2DInj- Atropree|
Dciproflerackn +etlet. Sn Bepanine ASnj: Noradrenet
D poracetamet tablet )Snj- ACK OSPae. C\Bnf- Awfodare
DAs Pata telat =) Levocetsiaine » Sri Furosemide DSi MS.
Beuroregwine talk 7) Mabvoni-| DSM: Cattum Giueonate |
@)Albendazols tates, Wazole.| 15 baloetotet 11) Sof Bigontn
A oncklengetrem tebe 46S] ID) OT Lorasepam 13)Suj-tyd cor
IDHomeprazroa fatoter Dn Uf peen 1D OEE.
1) Piclofenac fa Lar ID AritCre mye q ID)Srf De uttanntng.
State some sources of drug information, including examples of formularies
t Souacesi- Weu cotculatedt x.
[DReicaay Souaces aD | randourd sect controlled
DUnpubustsd stuctier, °
D origin Articles pubUshree fr reputed peer}
revieloen fournats veportiigg omfg ital reseasch
DSI RY SOS NEES
Dgezen SOS Meio Uegreptical references, Abshact.
D Tevtiany Sources 1— 4) Date bases) Tenctoootcs.
©) Re vous aatiete fn Pournalc
Identify the kind of drug information that may be available from patient package inserts /
patient information leaflets and drug formularies
PPI PIL Formulary
Yqenevia Kame Bi BYATE RAME. |i) Generia & Brandl Kame Stang
Dlompositien. BD Trerapertic,, |Detfreacy-
Ddosage B aduPufetration: A] satety profl of segs:
B)Waanings & Precautions - ID Onteraction profile:
>, Sick